Following a successful quality audit by Eevia Health Plc's ("Eevia" or "The Company") French auditor Natural Ingredients, Eevia has received an 85 KEUR sales order for Bilberry extract from its distributor.
Eevia Health Plc, ("Eevia" or "The Company"), has received a 20 KEUR sales order from a new Finnish customer.
Eevia Health Plc, ("Eevia" or "The Company"), has received a 96 KEUR sales order from a European nutraceutical brand owner.
Eevia Health Plc ("Eevia" or "The Company") is welcoming Dr. Tommi Kilpeläinen asits new Scientific Product Manager.
The Extraordinary General Meeting of Shareholders of Eevia Health Plc, corp. reg. no 2825194-4 (the "Company") was held on October 11, 2022 in Seinäjoki, Finland, whereby the shareholders primarily resolved the following matters:
Authorizing the Board of Directors to decide on the issuance of shares, options, and other special rights
Notice is given to the shareholders of Eevia Health Abp (Plc) to the Extraordinary General Meeting to be held on 11 October 2022 at 12:00 (Finnish time GMT +3) at the main office of Eevia Health Abp in Koulukatu 14, Seinäjoki, Finland.
The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 11:00.
Eevia Health Plc, ("Eevia" or "The Company"), has received two small starting sales orders from South Korea and Taiwan, totaling approx. 24 KEUR for organically certified bilberry extracts.
Eevia Health Plc ("Eevia" or "The Company") is releasing its quarterly financial report for the second quarter of 2022.
Eevia Health Plc ("Eevia" or "The Company") is welcoming Tuomas Jylhä as interim Chief Financial Officer. Gabriella Beni has decided to leave the Company for personal reasons to focus on private matters. Eevia wishes her the very best in her future endeavors. Tuomas Jylhä will take over the position on July 26th.
Analyst Group Initiates equity research Coverage of Eevia Health Plc, ("Eevia" or "The Company").